Targeting stroma to treat cancers.

Abstract

All cancers depend on stroma for support of growth. Leukemias, solid tumors, cancer cells causing effusions, metastases as well as micro-disseminated cancer cells release factors that stimulate stromal cells, which in turn produce ligands that stimulate cancer cells. Therefore, elimination of stromal support by destroying the stromal cells or by inhibiting feedback stimulation of cancer growth is in the focus of many evolving therapies. A stringent evaluation of the efficacy of stromal targeting requires testing in animal models. Most current studies emphasize the successes of stromal targeting rather than deciphering its limitations. Here we show that many of the stromal targeting approaches, while often reducing tumor growth rates, are rarely curative. Therefore, we will also discuss conditions where stromal targeting can eradicate large established tumors. Finally, we will examine still unanswered questions of this promising and exciting area of cancer research.

• Authors: Boris Engels, Donald A Rowley, Hans Schreiber
• Journal: Seminars in cancer biology (Semin Cancer Biol) Vol. 22 Issue 1 Pg. 41-9 (Feb 2012) ISSN: 1096-3650 [Electronic] England
• PMID: 22212863 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Review)
• Copyright: Copyright © 2011 Elsevier Ltd. All rights reserved.

Topics

• Disease Progression
• Humans
• Neoplasms (physiopathology, therapy)
• Paracrine Communication (physiology)
• Stromal Cells (physiology)